Abstract:In this viewpoint, we argue for the importance of creating data spaces for genomic research that are detached from contexts in which fundamental rights concerns related to surveillance measures override a purpose-specific balancing of fundamental rights. Genomic research relies on molecular and phenotypic data, on comparing findings within large data sets, on searchable metadata, and on translating research results into a clinical setting. These methods require sensitive genetic and health data to be shared across borders. International data sharing between the European Union (EU) or the European Economic Area and third countries has accordingly become a cornerstone of genomics. The EU General Data Protection Regulation contains rules that accord privileged status to data processing for research purposes to ensure that strict data protection requirements do not impede biomedical research. However, the General Data Protection Regulation rules applicable to international transfers of data accord no such preferential treatment to international data transfers made in the research context. The rules that govern the international transfer of data create considerable barriers to international data sharing because of the cost-intensive procedural and substantive compliance burdens that they impose. For certain jurisdictions and select use cases, there exist practically no lawful mechanisms to enable the international transfer of data because of concerns about the protection of fundamental rights. The proposed solutions further fail to address the need to share large data sets of local and regional cohorts across national borders to enable joint analyses. The European Health Data Space is an emerging federated, EU-wide data infrastructure that is intended to function as an infrastructure bringing together EU health data to improve patient care and enable the secondary use of health-related data for research purposes. Such infrastructure is implementing new institutions to support its functioning and is being implemented in reliance on a new enabling law, the regulation on the European Health Data Space. This innovation provides the opportunity to facilitate EU contribution to international genomic research efforts. The draft regulation for this data space provides for a concept of data infrastructure intended to enable cross-border data exchange and access, including access to genetic and health data for scientific analysis purposes. The draft regulation also provides for obligations of national actors aimed at making data widely available. This effort is laudable. However, in the absence of further, more fundamental changes to the manner in which the EU regulates the secondary use of health data, it is reasonable to believe that EU participation in international genomic research efforts will remain impeded.

Histamine metabolism in the pregnant mouse

Enabling responsible public genomics

Ethical and social implications of public–private partnerships in the context of genomic/big health data collection

Effect of Side Feed Pressurization on the Performance of Shimmed Foil Gas Bearings-Part II : Model , Predictions and Comparisons to Rotordynamic Measurements

Data storage and DNA banking for biomedical research: informed consent, confidentiality, quality issues, ownership, return of benefits. A professional perspective

Temperature regulation during exercise in water and air.

Future-proofing genomic data and consent management: a comprehensive review of technology innovations

Bridging the European Data Sharing Divide in Genomic Science

Balancing the local and the universal in maintaining ethical access to a genomics biobank

Exploring the potential duty of care in clinical genomics under UK law

The ethics weathervane

Demonstrating trustworthiness when collecting and sharing genomic data: public views across 22 countries

A call to action to scale up research and clinical genomic data sharing

Conducting a large, multi-site survey about patients' views on broad consent: challenges and solutions

Key Expert Stakeholder Perceptions of the Law of Genomics: Identified Problems and Potential Solutions

Raman spectroscopy: noninvasive determination of silicone oil in the eye: potential applications for intraocular determination of biomaterials.

"A very big challenge": a qualitative study to explore the early barriers and enablers to implementing a national genomic medicine service in England

Ethical issues raised by new genomic technologies: the case study of newborn genome screening

The Belgian DNA Debate: An Online Deliberative Platform on the Ethical, Legal, and Social Issues of Genomics

Privacy and ethical challenges in next-generation sequencing

Responsible data sharing in international health research: a systematic review of principles and norms